J. Scott Garland - Aug 16, 2021 Form 3 Insider Report for Day One Biopharmaceuticals, Inc. (DAWN)

Role
Director
Signature
/s/ By Charles N. York II, as Attorney-in-Fact for Reporting Person
Stock symbol
DAWN
Transactions as of
Aug 16, 2021
Transactions value $
$0
Form type
3
Date filed
8/18/2021, 07:02 PM
Previous filing
Jun 14, 2021
Next filing
Jun 3, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding DAWN No securities beneficially owned. 0 Aug 16, 2021 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Remarks:

Exhibit 24.1 Power of Attorney